Welcome!

News Feed Item

Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)

DUBLIN, Mar. 20, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug

) has announced the addition of the

"Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)"

conference to their offering.



(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The Injectable Drug Delivery Conference will be held on the 26th & 27th March 2014 at Le Meridien Hotel, Piccadilly, London



KEY TOPICS TO INCLUDE:


- Market trends


- Human factors and useability


- Fluid dynamics - modelling the realities of injection performance


- Delivery of high viscosity drugs


- Case study presentation on devices in development


- Latest self injection trends


- Development of a parenteral device


- Delivery of high volumes


- Compliance modelling and parenteral drug delivery


- The insulet drug delivery system



DATES:



26 & 27 March 2014



TIMES:



Day One: 26 March 2013


Start times: 9.30 Finish 17.45



Drinks Reception Followed by Dinner 19.30



Day Two: 27 March 2013


Start times: 9.00 Finish 16.15



VENUE FOR CONFERENCE AND DINNER:



Le Meridien Hotel, Piccadilly, London



NOTE: Please note that there is a Pre-conference seminar on 25th March on 'Prefilled Syringes - Advances in Manufacture' and also a Post Conference Workshop on 28th March on 'Human Factors and Usability Engineering in the development of drug delivery products'.



Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged



Key Topics Covered:



INJECTABLE DRUG DELIVERY DAY ONE - 26 March 2013



09.30 - Chairman's Welcome and Introduction


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.40 - Key Note Address: Market Trends



- High concentration formulations



- Larger doses, less frequent injections


Mathias Romacker, Drug Delivery Devices and Business Development, Amgen, USA



10.20 - Human Factors and Useability



- Ethonographic research on atuoinjector use for chronic conditions



- Relationship between a disease and its therapy - emotional and functional levels



- How this affects device selection


Mathew Young, CEO, Oval Medical Technologies Ltd, UK



11.00 - Discussion followed by Coffee



11.30 - Fluid Dynamics - Modelling the Realities of Injection Performance



- Mathematical modelling enables the opportunities and challenges of a range of device types to be explored early



- The implications of such characteristics as viscosity, dose volume and injection frequency are inseparable from the choice of delivery device



- Unfortunately, early consideration of the delivery device does not always take place. Opportunities can thus be lost and problems created which are costly and difficult to solve later



- Mathematical modelling techniques, applied properly, improve understanding of the issues concerned and enable better and earlier decisions to be taken



- Better informed decisions and better appreciations of the design options in turn support device designs which are better for the end user



- Early understanding of device issues supports and enables robust designs and capable manufacture



- Early understanding can shorten development timescales, in turn making earlier approval and earlier revenues possible


Andy Fry, Founder, Team Consulting, UK



12.10 - Delivery of High Viscosity Drugs



- Device formats



- Overcoming the challenges


Speaker, (invited)



12.50 - Discussion followed by Lunch



14.10 - Mixing Technologies for Reconstitution Devices



- Market Needs - Industry drivers and demands for these types of devices



- Latest mixing technologies



- Comparison of Lyophilised and Spray drying technologies



- Technical challenges with these types of devices


Tom Bailey, Managing Director, 3PInnovation, UK



14.50 - Device Case Study


Ian Anderson, Innovation Director, Bespak UK (invited)



15.30 - Discussion followed by Tea



16.10 - Latest Self Injection Trends



- General market trends



- Trends for biologics



- Trends for generics



- Pre-configured devices



- Future outlook


Mats Persson, Managing Director, SHL Group, Sweden



16.50 - Innovation in Primary Container Materials



- Trends for user requirements intended for self injection



- Material technology options and selection criteria



- Integration of Quality by Design for components



- Platform approach for lifecycle management


Tibor Hlobik, West Pharmaceutical Services



17.30 - Discussion



17.45 - End of Day One



19.30 - Drinks Reception Followed by Dinner at Le Meridien Hotel, London



INJECTABLE DRUG DELIVERY DAY TWO - 27 March 2013



09.00 - Review of Day One


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.10 - What Does Pharma Want From its Drug Delivery Suppliers


Nick Bowman, Senior Director, Head of Devices COE, Pfizer, UK



09.50 - Pump Technology Case Study


Jonathan Rigby, President & CEO, SteadyMed Therapeutics Inc, USA, (invited)



10.30 - Discussion followed by Coffee



11.10 - Compliance Monitoring and Parenteral Drug Delivery



- Why is the industry suddenly talking about compliance and adherence monitoring (clinical trials and commercial applications)



- Advances in wireless communications enabling intelligent compliance monitoring



- The widespread availability of smart devices and their use in compliance monitoring, adherence and patient education



- Use of smartphone / smart devices apps for providing real-time information display and the potential for two way communications with the patient



- Regulatory issues associated with connected health systems and smartphone apps



- Using the cloud to store and disseminate data securely


Mark Tuckwell, Senior Consultant, Connected Health Systems,


Sagentia, UK



11.50 - Wireless Communication and Electronics for Compliance Monitoring



- Patient therapy compliance continues to be one of the biggest challenges in health systems



- 50% of all patients do not complete required treatment



- Reasons for the high rate of non-compliance



- Opportunities for medical manufacturers to offer innovative solutions



- Electronic compliance aids open interesting possibilities to remind, monitor and track patients' behavior, as well as to share vital therapy information with healthcare providers



- Key technologies that facilitate compliance, ranging from low-cost disposable electronics for dose counts and logs to a complete cloud-based system for monitoring compliance


Lior Shtram, Director, Design & Engineering, Flextronics Medical, Israel



12.30 - Discussion followed by Lunch



14.00 - Update on Regulations and Standards


Lee Leichter, President P/L Medical, USA



14.40 - The Insulet Drug Delivery System



Consists of two components


- Drug Delivery Pod


- Drug Delivery Manager



A Programmable, body worn, disposable, subcutaneous infusion pump



- Delivers up to 2ml of drug product over a three day period


- Delivery rate from 0.5 to 300 µl/hr


- Automated catheter insertion


- Waterproof (IPX8 25 feet for up to 60 minutes)



Provides the HCP and user maximum control, versatility, comfort and safety, while overcoming the numerous drawbacks of conventional infusion pump systems


Kevin Schmid, Vice President, Business Development & Advanced Technology Insulet Corporation, USA



15.20 - The Rise of the Bolus Injector



The changing needs of patients and new drugs are driving the growth of a new class of injection device: the large volume' or bolus' injector. This presentation will report the findings of a new research project run in collaboration with the Judge Business School, covering:



- The changing needs of patients and new drugs



- Could autoinjectors and infusion pumps meet the needs?



- Bolus injectors: a new class of injection device



- Example devices



- What to expect from the draft standard ISO 11608-6' on bolus injectors.


Tom Oakley, Director of Drug Delivery Device Development, Springboard, UK



16.00 - Discussion and Chairman's Closing Remarks



16.15 - End of Conference and Tea




For more information visit

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug



Media Contact:

Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his session at 20th Cloud Expo, Mike Johnston, an infrastructure engineer at Supergiant.io, discussed how to use Kubernetes to set up a SaaS infrastructure for your business. Mike Johnston is an infrastructure engineer at Supergiant.io with over 12 years of experience designing, deploying, and maintaining server and workstation infrastructure at all scales. He has experience with brick and mortar data centers as well as cloud providers like Digital Ocean, Amazon Web Services, and Rackspace. H...
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, will provide a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to ...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
SYS-CON Events announced today that Massive Networks will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Massive Networks mission is simple. To help your business operate seamlessly with fast, reliable, and secure internet and network solutions. Improve your customer's experience with outstanding connections to your cloud.
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
As businesses adopt functionalities in cloud computing, it’s imperative that IT operations consistently ensure cloud systems work correctly – all of the time, and to their best capabilities. In his session at @BigDataExpo, Bernd Harzog, CEO and founder of OpsDataStore, presented an industry answer to the common question, “Are you running IT operations as efficiently and as cost effectively as you need to?” He then expounded on the industry issues he frequently came up against as an analyst, and ...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
SYS-CON Events announced today that Datera, that offers a radically new data management architecture, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Datera is transforming the traditional datacenter model through modern cloud simplicity. The technology industry is at another major inflection point. The rise of mobile, the Internet of Things, data storage and Big...
Given the popularity of the containers, further investment in the telco/cable industry is needed to transition existing VM-based solutions to containerized cloud native deployments. The networking architecture of the solution isolates the network traffic into different network planes (e.g., management, control, and media). This naturally makes support for multiple interfaces in container orchestration engines an indispensable requirement.
Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution and join Akvelon expert and IoT industry leader, Sergey Grebnov, in his session at @ThingsExpo, for an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience.
Because IoT devices are deployed in mission-critical environments more than ever before, it’s increasingly imperative they be truly smart. IoT sensors simply stockpiling data isn’t useful. IoT must be artificially and naturally intelligent in order to provide more value In his session at @ThingsExpo, John Crupi, Vice President and Engineering System Architect at Greenwave Systems, will discuss how IoT artificial intelligence (AI) can be carried out via edge analytics and machine learning techn...
FinTechs use the cloud to operate at the speed and scale of digital financial activity, but are often hindered by the complexity of managing security and compliance in the cloud. In his session at 20th Cloud Expo, Sesh Murthy, co-founder and CTO of Cloud Raxak, showed how proactive and automated cloud security enables FinTechs to leverage the cloud to achieve their business goals. Through business-driven cloud security, FinTechs can speed time-to-market, diminish risk and costs, maintain continu...
In his session at @ThingsExpo, Arvind Radhakrishnen discussed how IoT offers new business models in banking and financial services organizations with the capability to revolutionize products, payments, channels, business processes and asset management built on strong architectural foundation. The following topics were covered: How IoT stands to impact various business parameters including customer experience, cost and risk management within BFS organizations.
Existing Big Data solutions are mainly focused on the discovery and analysis of data. The solutions are scalable and highly available but tedious when swapping in and swapping out occurs in disarray and thrashing takes place. The resolution for thrashing through machine learning algorithms and support nomenclature is through simple techniques. Organizations that have been collecting large customer data are increasingly seeing the need to use the data for swapping in and out and thrashing occurs ...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that’s no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, will explore how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He wi...